Loading...

Bavarian Nordic A/S

BVNKFā€¢PNK
Healthcare
Biotechnology
$30.73
$0.00(0.00%)
U.S. Market opens in 2h 7m

Bavarian Nordic A/S (BVNKF) Stock Overview

Explore Bavarian Nordic A/Sā€™s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.4B
P/E Ratio11.19
EPS (TTM)$2.76
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$28.71
3 Months$29.62
1 Year Target$32.16

BVNKF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bavarian Nordic A/S (BVNKF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 60.60, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $32.16.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 11.19 and a market capitalization of 2.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.16%
3-Month Change
4.17%
6-Month Change
-16.99%
Year-to-Date (YTD) Change
4.17%
1-Year Change
33.15%
3-Year Change
13.73%
5-Year Change
-33.20%
All-Time (Max) Change
-11.31%

Contact Information

https://www.bavarian-nordic.com
45 33 26 83 83
Philip Heymans Alle 3, Hellerup, NaN, 2900

Company Facts

1,645 Employees
IPO DateOct 15, 2010
CountryDK
Actively Trading

Frequently Asked Questions